Old Web
English
Sign In
Acemap
>
authorDetail
>
Jeffery Scott Russell
Jeffery Scott Russell
Janssen Pharmaceutica
Cancer research
Medicine
Multiple myeloma
Orphan receptor
Immunotherapy
2
Papers
5
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Updated results of a phase 1, first-in-human study of talquetamab, a G protein-coupled receptor family C group 5 member D (GPRC5D) × CD3 bispecific antibody, in relapsed/refractory multiple myeloma (MM).
2021
Journal of Clinical Oncology
Jesus G. Berdeja
Amrita Krishnan
Albert Oriol
Niels W.C.J. van de Donk
Paula Rodriguez-Otero
Elham Askari
Maria-Victoria Mateos
Monique C. Minnema
Luciano J. Costa
Raluca Verona
Suzette Girgis
Thomas J Prior
Brandi Hilder
Jeffery Scott Russell
Jenna D. Goldberg
Ajai Chari
Show All
Source
Cite
Save
Citations (5)
Teclistamab and talquetamab modulate levels of soluble B-cell maturation antigen in patients with relapsed and/or refractory multiple myeloma.
2021
Journal of Clinical Oncology
Suzette Girgis
Shun Xin Wang Lin
Kodandaram Pillarisetti
Raluca Verona
Diego Vieyra
Tineke Casneuf
Damien Fink
Xin Miao
Yang Chen
Tara Stephenson
Arnob Banerjee
Brandi Hilder
Jeffery Scott Russell
Jennifer Smit
Jenna D. Goldberg
Show All
Source
Cite
Save
Citations (0)
1